Skip to main content
. 2024 Jul 12;75(3):228–236. doi: 10.3164/jcbn.24-79

Fig. 1.

Fig. 1.

Serological Vit-D and per-allele risk estimates in odds ratio (OR) for the primary endpoint of AF and/or ischemic stroke. Serological Vit-D deficiency independently predicted the primary endpoint of AF and/or ischemic stroke [OR = 1.77 (95% CI 1.24 to 2.52), p = 0.002] in the HKU-TRS. Higher genetically predicted Vit-D, denoted by GRS, independently predicted reduced risk of AF and/or ischemic stroke [OR = 0.83 (0.72 to 0.95), p = 0.008]. Predictive estimates of other candidate genetic variants or combinations provided sensitivity analyses which corroborated similar findings.